NCT03383991

Brief Summary

Proximal humeral fractures are common injuries with the highest incidence being amongst the elderly. Most proximal humeral fractures are nondisplaced or minimally displaced. The majority of these are reliably treated nonoperatively with an acceptable functional outcome. The treatment of displaced fractures is more controversial. Consensus is lacking as to when surgery is indicated or what type of procedure to choose if surgery is elected. Displaced 3- and 4-part fractures where internal fixation is deemed unreliable have been considered an indication for hemiarthroplasty. Hemiarthroplasty gives reasonable control of pain but the resulting shoulder function and range of motion is unpredictable. The use of reverse total shoulder arthroplasty is increasing and might result in a better range of motion then hemiarthroplasty. The aim of this multicenter study is to test the hypothesis that reverse total shoulder arthroplasty gives better shoulder function than hemiarthroplasty for displaced 3- and 4-part proximal humeral fractures.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Timeline
Completed

Started Sep 2013

Longer than P75 for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 10, 2013

Completed
4.3 years until next milestone

First Submitted

Initial submission to the registry

December 14, 2017

Completed
13 days until next milestone

First Posted

Study publicly available on registry

December 27, 2017

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 2, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 2, 2020

Completed
Last Updated

September 2, 2020

Status Verified

September 1, 2020

Enrollment Period

7 years

First QC Date

December 14, 2017

Last Update Submit

September 1, 2020

Conditions

Keywords

Humeral Fracture, ProximalArthroplasty, Replacement, ShoulderReverse Total Shoulder ArthroplastyShoulder Hemiarthroplasty

Outcome Measures

Primary Outcomes (2)

  • Constant-Murley Score

    The Constant-Murley score is used to assess shoulder function. The maximum score is 100 points. Higher scores represent better shoulder function.

    24 months

  • WOOS (Western Ontario Osteoarthritis of the Shoulder) Index

    24 months

Study Arms (2)

Reverse Total Shoulder Arthroplasty

EXPERIMENTAL
Procedure: Reverse Total Shoulder Arthroplasty

Hemiarthroplasty

ACTIVE COMPARATOR
Procedure: Hemiarthroplasty

Interventions

Reverse Total Shoulder Arthroplasty
Hemiarthroplasty

Eligibility Criteria

Age70 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • Displaced 3- or 4-part fracture of the proximal humerus
  • Age over 70 years
  • Independent living
  • Low energy trauma

You may not qualify if:

  • Pre-existing shoulder disease
  • Severe cognitive dysfunction
  • More than 14 days from injury to surgery
  • Comorbidity that affects shoulder rehabilitation considerably
  • Concurrent injury that affect shoulder rehabilitation considerably

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Handoll HH, Elliott J, Thillemann TM, Aluko P, Brorson S. Interventions for treating proximal humeral fractures in adults. Cochrane Database Syst Rev. 2022 Jun 21;6(6):CD000434. doi: 10.1002/14651858.CD000434.pub5.

MeSH Terms

Conditions

Shoulder Fractures

Interventions

Hemiarthroplasty

Condition Hierarchy (Ancestors)

Fractures, BoneWounds and InjuriesShoulder Injuries

Intervention Hierarchy (Ancestors)

Arthroplasty, ReplacementArthroplastyOrthopedic ProceduresSurgical Procedures, OperativePlastic Surgery ProceduresProsthesis Implantation

Study Officials

  • Per Olerud, MD

    Karolinska Institutet

    PRINCIPAL INVESTIGATOR
  • Carl Ekholm, MD

    Sahlgrenska Academy

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD, PhD, Senior Consulting Orthopedic Surgeon

Study Record Dates

First Submitted

December 14, 2017

First Posted

December 27, 2017

Study Start

September 10, 2013

Primary Completion

September 2, 2020

Study Completion

September 2, 2020

Last Updated

September 2, 2020

Record last verified: 2020-09